Loading…
Loading…
iShares Trust - iShares MSCI China Small-Cap ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of China. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of small-cap companies. The fund seeks to track the performance of the MSCI China Small Cap Index, by using representative sampling technique. iShares Trust - iShares MSCI China Small-Cap ETF was formed on September 28, 2010 and is domiciled in the United States.
Is ECNS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Once a great contrarian, long-term buy, Chinese equities have gained significantly and are now closer to fair value. Value could be found in overlooked Chinese small caps. The iShares MSCI China Small-Cap ETF tracks the MSCI China Small Cap Index, but its high 0.59% expense ratio and 61% turnover rate raise concerns for long-term investors. Roughly 75% of ECNS's sampled holdings are profitable, but many exhibit low business quality.
iShares MSCI China Small-Cap ETF is rated a Strong Buy due to resilience against U.S. tariffs and attractive dividend yield. ECNS benefits from high diversification, a stable 4.5% yield, and sector exposure to less volatile industries like healthcare and industrials. Chinese companies, including the fund's constituents, are adapting to tariffs by shifting supply chains and markets, lessening the intended U.S. tariff impact.
Getting emerging market exposure is a viable option in the current market environment. That's especially so given the global de-dollarization and prospect of further rate cuts by the Federal Reserve.
The iShares MSCI China Small-Cap ETF (ECNS) offers exposure to Chinese small caps but suffers from high volatility, poor tracking capabilities, and significant underperformance. ECNS's annual turnover and volatility are much higher than typical ETFs, and its sector allocation leans heavily toward low-growth healthcare stocks. Despite a decent 4% yield and a significant valuation discount to peers, ECNS's risk-adjusted returns lag both Chinese large-caps and EM small-caps.
MCHI, with over $7B in AUM, covers around 550 Chinese stocks, most of which are giant-caps and come in varied share classes. We highlight who MCHI would be best suited for. There are some key risks associated with this ETF that investors should be aware of.